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lin-2-one derivatives were synthesized by treating 5-(4-aminophenyl)-1,3,4-oxadiazole-2-thiol with
different isatin derivatives. The newly synthesized compounds were characterized on the basis of
spectral (FT-IR, 1H NMR, MS) analyses. All the synthesized derivatives were screened for antican-
cer activity against HeLa cancer cell lines using MTT assay. All the synthetic compounds produced
a dose dependant inhibition of growth of the cells. The IC50 values of all the synthetic test com-
pounds were found between 10.64 and 33.62 lM. The potency (IC50 values) of anticancer activity
of compounds VIb–d was comparable with that of known anticancer agent, Cisplatin. Among the
synthesized 2-indolinones, compounds VIb–d with halogen atom (electron withdrawing groups) at
C5 position showed the most potent activity. These results indicate that C5 substituted derivatives
may be useful leads for anticancer drug development in the future.
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lsevier1. Introduction
The development of new anticancer therapeutic agents is one
of the fundamental goals in medicinal chemistry. Cytotoxicity
and genotoxicity of anticancer drugs to the normal cells are
major problems in cancer therapy and engender the risk of
inducing secondary malignancy (Aydemir and Bilaloglu,
2003). A dose of anticancer drug sufﬁcient to kill tumor cells
is often toxic to the normal tissue and leads to many side ef-
fects, which in turn, limits its treatment efﬁcacy. In recent
years, there has been a concerned search for the discovery
and development of novel selective anticancer agents, devoid
of many of the unpleasant side effects of conventional
154 R. Gudipati et al.anticancer agents. The synthesis of a newer class of anticancer
agents is in need of time.
Literature survey revealed that isatin (1H-indole-2,3-dione)
possesses diverse chemotherapeutic activities, such as anticancer
(Gursoy and Karal, 2003), antiviral (Debra et al., 2006), anti-
HIV (Pandeya et al., 1999a), anti-mycobacterial (Karal et al.,
2007), antibacterial (Pandeya et al., 1999b), anti-inﬂammatory
(Sridhar and Ramesh, 2001) and anticonvulsant (Verma et al.,
2004). Among these properties, cytotoxic and antineoplastic
activities of this moiety have been found to be interesting. It
has been reported in the literature that compounds bearing
1,3,4-oxadiazole ring possess signiﬁcant biological properties
such as anticancer (Aboraia et al., 2006), anti-inﬂammatory
(Nargund et al., 1994), hypoglycemic (Ladduwahetty et al.,
1996), antifungal, antibacterial (Khanum et al., 2005), antitu-
bercular (Mamolo et al., 2005), analgesic (Bhandari et al.,
2008), antiviral (Kucukguzel et al., 2007) activities.
In view of the biological importance of these isatin and 1,3,4-
oxadiazole moieties, it was planned to synthesize a new series of
isatin derivatives containing 1,3,4-oxadiazole i.e. 5- or 7-substi-
tuted 3-{4-(5-mercapto-1,3,4-oxadiazol-2-yl) phenylimi-
no}indolin-2-ones and were evaluated for in vitro anticancer
activity against HeLa (cervical), IMR-32 (neuroblastoma) &
MCF-7 (breast) cancer cell lines using MTT assay.
2. Materials and methods
2.1. General
Melting points (mp) were determined in open capillaries, using
Toshniwal melting point apparatus, expressed in C and are
uncorrected. The IR spectra of the compounds were recorded
on thermo Nicolet Nexus 670S series, FT-IR spectrometer
using KBr disc. 1H NMR was scanned on Avance-400 MHz
instrument. Chemical shifts are expressed in d (ppm) relative
to TMS as an internal standard using DMSO-d6 as solvent.
Mass spectra were recorded on a LC-MSD-Trap-SL. The pur-
ity of the compounds was checked on silica gel-coated alumi-
num sheets (Merck, 1.005554, silica gel HF254–361, Type 60,
0.25 mm, Darmstadt, Germany) by thin-layer chromatogra-
phy (TLC). TLC was performed on silica gel G for TLC
(Merck) and spots were visualized by iodine vapor or by irra-
diation with ultraviolet light (short wave length, 254 nm). Col-
umn chromatography was performed by using Qualigen’s
silica gel for column chromatography (60–120 mesh).
2.2. Chemicals
All the solvents, reagents and catalysts used are of AR grade.
Isatin, fetal bovine serum (FBS), Dulbecco’s modiﬁed eagle’s
medium (DMEM), penicillin, amphotericin B, and streptomy-
cin were purchase from Himedia (Mumbai, India). 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) was purchased from Sigma Chemical Company (St.
Louis, MO, USA). Substituted isatins were prepared by the
procedures reported in the literature (Bahl, 2004).
2.3. Cell cultures
The cell cultures like HeLa (cervical), IMR-32 (neuroblastoma)
& MCF-7 (breast) cancer cell lines were purchased from theNational Centre for Cell sciences (NCCS), Pune, India. These
cell lines were grown and maintained using suitable (DMEM)
media and were grown in culture medium supplemented with
10% fetal bovine serum, 1% L-glutamine and 1% penicillin-
streptomycin-amphotericin B antibiotic solution. Cells were
seeded in 25 cm2 tissue culture ﬂasks (tarsons, India), at
250,000 cells/ﬂask in a total volume of 9 ml. When conﬂuent,
all the cells were trypsinized (using Trypsin-EDTA, HiMedia,
Mumbai, India), and seeded in 96-well plates (tarsons, India).
2.4. Chemistry
2.4.1. Synthesis of isatin derivatives
The different (5- or 7-substituted) isatin derivatives were pre-
pared as reported in the literature (Henry and Blatt, 1964).
2.4.2. Synthesis of N-(4-[hydrazinecarbonyl] phenyl)
acetamide (IV)
N-(4-[Hydrazinecarbonyl] phenyl) acetamide (IV) was pre-
pared from ethyl-p-acetamido benzoate (III) as reported in
the literature (Varma and Chauhan, 1988).
2.4.3. Synthesis of 5-{4-(aminophenyl)-1,3,4-oxadiazol}-2-thiol
(V)
5-{4-(Aminophenyl)-1,3,4-oxadiazol}-2-thiol (V) was synthe-
sized from N-(4-[hydrazinecarbonyl] phenyl) acetamide (IV)
by adopting the procedure mentioned by Khanum et al. (2005).
2.4.4. Synthesis of 3-{4-(5-mercapto-1,3,4-oxadiazol-2-yl)
phenylimino}-5 or 7-substituted-indolin-2-one (VI)
5-{4-(Aminophenyl)-1,3,4-oxadiazol}-2-thiol (compound V;
1.93 g, 0.01 mol) and Isatin (1.47 g, 0.01 mol) were reﬂuxed
in 20 ml of ethanol in the presence of a catalytic amount of gla-
cial acetic acid (2–3 drops) for 5–6 h and cooled. The solid sep-
arated was ﬁltered and washed with cold alcohol and the
product obtained was recrystallized from methanol (yield:
2.41 g, 75%), m.p. 268–270 C)
2.4.5. Spectral data of synthesized compounds (VIa–k)
2.4.5.1. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
indolin-2-one (VIa). IR t (cm1): 1264 (C‚S), 1676 (C‚O),
3432 (N–H of amide), 1533 (C‚N) and 1184 (ether, C–O–
C); 1H NMR (DMSO-d6) d ppm: 7.45–7.62 (m, 4H, Ar–H),
7.75–7.85 (m, 4H, Ar–H), 7.81 (s, 1H, SH), 10.27 (s, 1H, indole
NH), ESI: m/z value 323.2.
2.4.5.2. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
5-ﬂouro-indolin-2-one (VIb). IR t (cm1): 1261 (C‚S), 1667
(C‚O), 3220 (N–H of amide), 1547 (C‚N), 1165 (ether, C–
O–C) and 759 (C–F); 1H NMR (DMSO-d6) d ppm: 6.99 (d,
1H, Ar–H), 7.3–7.6 (m, 5H, Ar–H), 7.65 (s, 1H, Ar–H), 7.89
(s, 1H, SH), 10.21 (s, 1H, indole NH), ESI: m/z value 341.0.
2.4.5.3. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
5-bromo-indolin-2-one (VId). IR t (cm1): 1271 (C‚S), 1682
(C‚O), 3177 (N–H of amide), 1534 (C‚N), 1151 (C–N),
1151 (ether, C–O–C) and 662 (C-Br); 1H NMR (DMSO-d6)
d ppm: 7.10 (d, 1H, Ar–H), 7.16–7.43 (m, 5H, Ar–H),7.52 (s,
1H, Ar–H), 7.88 (s, 1H, SH), 10.3 (s, 1H, indole NH), ESI:
m/z value 411.1.
Synthesis, characterization and anticancer activity 1552.4.5.4. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
5-methyl-indolin-2-one (VIe). IR t (cm1): 1261 (C‚S), 2918
(C–H of CH3), 1682 (C‚O), 3330 (N–H of amide), 1534
(C‚N), 1151 (ether, C–O–C); 1H NMR (DMSO-d6) d ppm:
2.25 (s, 3H, CH3), 6.45–6.55 (d, 1H, Ar–H), 6.8–7.1 (m, 5H,
Ar–H), 7.15 (s, 1H, Ar–H), 7.30 (s, 1H, SH), 10.13 (s, 1H, in-
dole NH), ESI: m/z value 337.0.
2.4.5.5. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
5-nitro-indolin-2-one (VIf). IR t (cm1): 1250 (C‚S), 1670
(C‚O), 3201 (N–H of amide), 1527 (C‚N), 1148 (ether, C–
O–C), 1405 (N‚O str, asy), 1345 (N‚O str, sym); 1H NMR
(DMSO-d6) d ppm: 7.01 (d, 1H, Ar–H), 7.2–7.5 (m, 5H, Ar–
H), 7.58 (s, 1H, Ar–H), 7.58 (s, 1H, SH), 10.15 (s, 1H, indole
NH), ESI: m/z value 368.0.
2.4.5.6. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
5-carboxylic acid-indolin-2-one (VIg). IR t (cm1): 1241
(C‚S), 1700 (C‚O of COOH), 1318 (CO str of COOH),
3316 (N–H of amide),1600 (C‚O), 1525 (C‚N), and 1178
(ether, C–O–C); 1H NMR (DMSO-d6) d ppm: 6.5–6.52 (d,
1H, Ar–H), 6.7–7.0 (m, 5H, Ar–H), 7.14 (s, 1H, Ar–H), 7.59
(s, 1H, SH), 10.10 (s, 1H, indole NH), 12.5 (s, 1H, COOH),
ESI: m/z value 367.1.
2.4.5.7. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
7-chloro-indolin-2-one (VIh). IR t (cm1): 1180 (C‚S), 1618
(C‚O), 3315 (N–H of amide), 1525 (C‚N), 1024 (ether, C–
O–C) and 731 (C–Cl); 1H NMR (DMSO-d6) d ppm: 7.0–7.4
(m, 5H, Ar–H),7.4–7.6 (t, 1H, Ar–H), 7.6 (d, 1H, Ar–H), 7.7
(s, 1H, SH), 11.09 (s, 1H, indole NH), ESI: m/z value 358.
2.4.5.8. 3-(4-[5-Mercapto-1,3,4-oxadiazole-2-yl] phenylimino)-
7-carboxylic acid-indolin-2-one (VIk). IR t (cm1): 1268
(C‚S), 3313 (OH of COOH), 1609 (C‚O), 1710 (C‚O of
COOH), 3200 (N–H of amide), 1498 (C‚N), and 1027 (ether,
C–O–C); 1H NMR (DMSO-d6) d ppm: 7.1–7.4 (m, 5H, Ar–H),
7.2–7.4 (t, 1H, Ar–H), 7.6 (d, 1H, Ar–H), 7.8 (s, 1H, SH), 12.7
(s, 1H, COOH), 11.18 (s, 1H, indole NH), ESI: m/z value 367.H2N COOH
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Scheme 1 Synthesis of 3-{4-(5-mercapto-1,3,4-oxadiazol-2-yl)3. Biological activity
3.1. Evaluation of in vitro anticancer activity against HeLa,
IMR-32 & MCF-7 cancer cell lines
In vitro anticancer activity againstHeLa, IMR-32&MCF-7 can-
cer cell lines was determined (Monks et al., 1991; Skehan et al.,
1990) using 96-well tissue culture plates. The cell suspension of
1 · 105 cells/ml was prepared in complete growthmedium. Stock
solutions of compounds (14) were prepared inDMSO.The stock
solutions were serially diluted with complete growth medium
containing 50 mg/ml of gentamycin to obtain working test solu-
tion of required concentrations (having <1% DMSO). The
100 lL of cell suspension was added to each well of the 96-well
tissue culture plates. The cells were allowed to grow in CO2 incu-
bator (37 C, 5%CO2, 90% relative humidity) for 24 h. The test
materials in complete growth medium (100 lL) were added after
24 h incubation to thewells containing cell suspension.After 48 h
of treatmentwithdifferent concentrationsof test compounds, the
cells were incubated withMTT (2.5 mg/ml) for 2 h. The medium
was then removed and 100 ll of DMSO were added into each
well to dissolve formazan crystals, the metabolite of MTT. After
thoroughly mixing, the plate was read at 490 nm for optical den-
sity that is directly correlated with cell quantity.
4. Results and discussion
4.1. Chemistry
In the present study, the compounds were synthesized as de-
picted in Scheme 1. Twelve different novel 3-{4-(5-mercapto-
1,3,4-oxadiazol-2-yl) phenylimino}-5 or 7-substituted-indolin-
2-one derivatives (VIa–l) were prepared by treating 5-(4-[ami-
nophenyl)-1,3,4-oxadiazole-2-thiol with different isatin deriva-
tives. The preparation of the title derivatives is outlined in
Scheme 1. The physical data of the all synthesized compounds
were shown in Table 1. All the synthesized compounds were
puriﬁed by column chromatography using ethyl acetate, chlo-H2N COO
Ac2O
H3COCHN COO
III
II
O
O
2H5OH NH
N
O
R1
R2
NN
O SH
VI
COOC2H5
COOC2H5
phenylimino}-5 or 7-substituted indolin-2-one derivatives.
Table 1 Physical data of all synthesized test compounds (VIa–l).
S. No. Compound Mol. formula R1 R2 Mol. wt % Yield m.p. (C)
1 VIa C16H10O2N4S H H 322 61 268–270
2 VIb C16H9O2N4SF F H 340 70 288–289
3 VIc C16H9O2N4SCl Cl H 356 72 262–264
4 VId C16H9O2N4SBr Br H 401 70 198–202
5 VIe C17H12O2N4S CH3 H 336 71 280–282
6 VIf C16H9O4N5S NO2 H 367 63 292–293
7 VIg C17H10O4N4S COOH H 366 64 220–224
8 VIh C16H9O2N4SCl H Cl 357 72 160-162
9 VIi C16H9O4N5S H NO2 367 69 264–265
10 VIj C17H12O2N4S H CH3 336 68 210–212
11 VIk C17H10O4N4S H COOH 366 67 198–199
12 VIl C18H12O4N4S H COOCH3 380 62 238–240
Table 2 Anticancer activity of synthesized compounds against HeLa, IMR-32 & MCF-7 cancer cells using MTT assay.
S. No. Compound R1 R2 IC50 (lM)
* (HeLa) IC50 (lM)
* (IMR-32) IC50 (lM)
* (MCF-7)
1 Isatin 521.9 352.74 410.95
2 V (Intermediate) 309.59 176.85 206.95
3 VIa H H 25.47 30.65 33.62
4 VIb F H 11.99 13.48 15.57
5 VIc Cl H 12.84 15.84 16.68
6 VId Br H 10.64 12.68 16.06
7 VIe CH3 H 22.59 27.25 29.38
8 VIf NO2 H 18.60 22.51 24.48
9 VIg COOH H 17.25 20.85 22.95
10 VIh H Cl 18.69 22.51 24.92
11 VIi H NO2 16.20 19.35 20.38
12 VIj H CH3 15.12 18.32 20.95
13 VIk H COOH 20.36 24.28 25.98
14 VIl H COOCH3 19.32 23.85 25.18
15 Cisplatin 14.08 13.64 13.54
Values are expressed as means (n= 4).
156 R. Gudipati et al.roform and methanol as solvent and the reactions were moni-
tored by TLC. The chemical structures of the synthesized com-
pounds (Table 1) were conﬁrmed by means of their IR, 1H
NMR and MS spectral analysis.
4.2. In vitro anticancer activity
The anticancer activity of all the synthesized compounds (VIa–
l) was evaluated against HeLa, IMR-32 & MCF-7 cancer celllines using MTT method and the IC50 values of all the com-
pounds including the intermediate were shown in Table 2.
All the synthetic compounds produced a dose dependant inhi-
bition of growth of the cells. The IC50 values of all the syn-
thetic test compounds were found between 10.64 and
33.62 lM. The IC50 of these compounds were comparable with
known anticancer agent, Cisplatin (IC50 value between 13.54
and 14.08). The present study reveals that among the human
cancer cell lines tested, HeLa cells are slightly more sensitive
Synthesis, characterization and anticancer activity 157to all the tested compounds than IMR-32 & MCF-7 cells.
Many anticancer drugs are effective against HeLa, IMR-32
& MCF-7 cells by causing apoptosis through the expression
of caspase-3, generating reactive oxygen species (ROS) and
damaging DNA (Leong et al., 2003). Cisplatin causes cytotox-
icity in MCF-7 and HeLa cells by a similar mechanism (Osbild
et al. 2006).
Results indicate that the anticancer or cytotoxicity of deriv-
atives varied with structural modiﬁcation. Among the synthe-
sized 2-indolinones, compounds VIb–d with halogen atom
(electron withdrawing groups) at C5 position showed the most
potent activity than other synthesized compounds. This is not
surprising, as C5 substitution has previously been associated
with increased biological activity for a range of indole-based
compounds (Cane et al., 2000; Lee et al., 2001). Previous stud-
ies have shown that strong electronegative atom substitution
such as chloro/bromo at the C5 position of the aromatic ring
increases the lipophilicity of molecules and is responsible for
enhanced cytotoxicity in MTT model (Hari et al., 2008). Sim-
ilar substitutions are present in the compounds VIb–d. We
have also observed enhanced cytotoxicity in these molecules.
5. Conclusions
A new series of 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl)phe-
nylimino)-5 or 7-substituted indolin-2-one derivatives were
synthesized. The synthesized compounds were active as growth
inhibitors of the test HeLa, IMR-32 &MCF-7 cancer cell lines.
Among all the synthesized compounds, 5-halo substituted
compounds (VIb–d) were found to be the most potent antican-
cer agents in our study. These results indicate that C5 substi-
tuted derivatives may be useful leads for anticancer drug
development in the future.Acknowledgments
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